SEC Info - Angiotech Pharmaceuticals Inc, et al. - ‘F-10/A’ on 12/13/06

SEC Info℠

Home

Help

Please Sign In

Angiotech Pharmaceuticals Inc, et al. – ‘F-10/A’ on 12/13/06

On: Wednesday, 12/13/06, at 4:24pm ET · Accession #: 1193125-6-252478 · File #s: 333-138185, -01, -02, -03, -04, -05, -06, -07, -08, -09, -10, -11, -12, -13, -14, -15, -16, -17, -18, -19, -20, -21, -22, -23, -24, -25, -26, -27, -28, -29, -30, -31, -32, -33, -34

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

12/13/06  Angiotech Pharmaceuticals Inc     F-10/A                 4:1.5M                                   RR Donnelley/FA
          Tercentenary Holdings, Corp.
          Point Technologies, Inc.
          Angiotech Investment Partnership
          3129539 Nova Scotia Co
          Quill Medical, Inc.
          Manan Medical Products, Inc.
          American Medical Instruments Holdings, Inc.
          3129540 Nova Scotia Co
          3091799 Nova Scotia Co
          3091797 Nova Scotia Co
          Surgical Specialties Corp.
          Medical Device Technologies, Inc.
          Afmedica, Inc.
          3129537 Nova Scotia Co
          Surgical Specialties Puerto Rico, Inc.
          NeuColl, Inc.
          B.G. Sulzle, Inc.
          3132936 Nova Scotia Co
          3129538 Nova Scotia Co
          American Medical Instruments, Inc.
          Crimson Cardinal Capital, Inc.
          3091796 Nova Scotia Co
          Angiotech Pharmaceuticals (US), Inc.
          Angiotech Capital, LLC
          Angiotech International Holdings, Corp.
          3132934 Nova Scotia Co
          Surgical Specialties UK Holdings Ltd
          3132935 Nova Scotia Co
          0741693 B.C. Ltd.
          3129541 Nova Scotia Co
          3091798 Nova Scotia Co
          3132933 Nova Scotia Co
          Angiotech BioCoatings Corp.
          0761717 B.C. Ltd.

Pre-Effective Amendment to Registration Statement of a Foreign Private Issuer (Not Effective Immediately) — Form F-10
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: F-10/A      Amendment No. 1 to Form F-10                        HTML   1.30M 
 2: EX-23.1     Consent of Ernst & Young LLP                        HTML     16K 
 3: EX-23.2     Consent of Pricewaterhousecoopers LLP               HTML     14K 
 4: EX-23.3     Consent of Hughes Pittman & Gupton LLP              HTML     14K

Filing Submission 0001193125-06-252478 – SGML Text

Original SGML Text submitted by:	Donnelley Financial Solutions/FA (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Angiotech Pharmaceuticals Inc, et al. – ‘F-10/A’ on 12/13/06

On: Wednesday, 12/13/06, at 4:24pm ET · Accession #: 1193125-6-252478 · File #s: 333-138185, -01, -02, -03, -04, -05, -06, -07, -08, -09, -10, -11, -12, -13, -14, -15, -16, -17, -18, -19, -20, -21, -22, -23, -24, -25, -26, -27, -28, -29, -30, -31, -32, -33, -34

Previous ‘F-10’: ‘F-10’ on 10/25/06 · Next: ‘F-10’ on 3/8/07 · Latest: ‘F-10/A’ on 4/2/07

Pre-Effective Amendment to Registration Statement of a Foreign Private Issuer (Not Effective Immediately) — Form F-10Filing Table of Contents

To view the SGML, please refresh this page.

Pre-Effective Amendment to Registration Statement of a Foreign Private Issuer (Not Effective Immediately) — Form F-10
Filing Table of Contents

To view the SGML, please refresh
this page.